Robinhood has reached $377 billion in assets on its platform, a 48% increase from last year, and introduced Robinhood Earn, a new lending product allowing eligible US users to lend USDG stablecoins through Morpho's on-chain credit network. This product offers an estimated 7% annual yield, significantly higher than traditional savings accounts, and is backed by insurance from Lloyd's of London. The integration leverages Morpho for lending mechanics, Steakhouse Financial for vault infrastructure, and Robinhood Chain for transaction settlement, marking a major step in bringing decentralized finance to Robinhood's 27.7 million funded customers. This move highlights Robinhood's push into DeFi, aiming to make on-chain finance accessible to mainstream retail investors.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
